Norges Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $356M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $482M | Buy |
|
|||||
|
2024
Q1 | $328M | Buy |
|
|||||
|
2023
Q4 | $379M | Sell |
|
|||||
|
2023
Q3 | $393M | Buy |
|
|||||
|
2023
Q2 | $410M | Buy |
|
|||||
|
2023
Q1 | $383M | Buy |
|
|||||
|
2022
Q4 | $362M | Buy |
|
|||||
|
2022
Q3 | $332M | Buy |
|
|||||
|
2022
Q2 | $241M | Sell |
|
|||||
|
2022
Q1 | $289M | Sell |
|
|||||
|
2021
Q4 | $373M | Sell |
|
|||||
|
2021
Q3 | $459M | Sell |
|
|||||
|
2021
Q2 | $631M | Buy |
|
|||||
|
2021
Q1 | $490M | Sell |
|
|||||
|
2020
Q4 | $466M | Sell |
|
|||||
|
2020
Q3 | $572M | Sell |
|
|||||
|
2020
Q2 | $572M | Sell |
|
|||||
|
2020
Q1 | $703M | Sell |
|
|||||
|
2019
Q4 | $716M | Buy |
|
|||||
|
2019
Q3 | $525M | Buy |
|
|||||
|
2019
Q2 | $483M | Buy |
|
|||||
|
2019
Q1 | $487M | Sell |
|
|||||
|
2018
Q4 | $645M | Sell |
|
|||||
|
2018
Q3 | $764M | Sell |
|
|||||
|
2018
Q2 | $630M | Buy |
|
|||||
|
2018
Q1 | $581M | Sell |
|
|||||
|
2017
Q4 | $690M | Buy |
|
|||||
|
2017
Q3 | $632M | Buy |
|
|||||
|
2017
Q2 | $547M | Sell |
|
|||||
|
2017
Q1 | $575M | Sell |
|
|||||
|
2016
Q4 | $604M | Buy |
|
|||||
|
2016
Q3 | $612M | Buy |
|
|||||
|
2016
Q2 | $459M | Buy |
|
|||||
|
2016
Q1 | $473M | Sell |
|
|||||
|
2015
Q4 | $596M | Sell |
|
|||||
|
2015
Q3 | $577M | Buy |
|
|||||
|
2015
Q2 | $677M | Buy |
|
|||||
|
2015
Q1 | $697M | Buy |
|
|||||
|
2014
Q4 | $559M | Hold |
|
|||||
|
2014
Q3 | $544M | Sell |
|
|||||
|
2014
Q2 | $1.04B | Buy |
|
|||||
|
2014
Q1 | $511M | Hold |
|
|||||
|
2013
Q4 | $468M | Sell |
|
|||||
|
2013
Q3 | $415M | Sell |
|
|||||
|
2013
Q2 | $398M | Buy |
|